Search research articles
Contact Us
Filters
Showing results (41-50 of 185) with videos related to
Page
of 19
Sort By:
Oncotarget
|
December 30, 2014
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
Chiara Agnoletto, Laura Brunelli, Elisabetta Melloni, et al.
Blood
|
December 1, 2005
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion
Gian Matteo Rigolin, Chiara Fraulini, Maria Ciccone, et al.
Blood
|
October 18, 2002
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia
Stefano Molica, Angelo Vacca, Domenico Ribatti, et al.
Hematological Oncology
|
September 7, 2018
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper
Antonio Cuneo, Giovanni Barosi, Romano Danesi, et al.
Oncotarget
|
June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.
Blood
|
January 10, 2002
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
Elena Adinolfi, Loredana Melchiorri, Simonetta Falzoni, et al.
European Journal of Haematology
|
October 2, 2004
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings
Gian Matteo Rigolin, Matteo Della Porta, Anna Maria Bugli, et al.
Haematologica
|
December 18, 2023
Towards personalized prevention of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an <I>ad hoc</I> Italian expert panel
Corrado Girmenia, Fabio Ciceri, Paolo Corradini, et al.
Oncotarget
|
September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 19, 2019
Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the <i>MYD88</i> L265P Gene Mutation
Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 185) with videos related to
Sort By:
Page
of 19
Oncotarget
|
December 30, 2014
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway
Chiara Agnoletto, Laura Brunelli, Elisabetta Melloni, et al.
Blood
|
December 1, 2005
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion
Gian Matteo Rigolin, Chiara Fraulini, Maria Ciccone, et al.
Blood
|
October 18, 2002
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia
Stefano Molica, Angelo Vacca, Domenico Ribatti, et al.
Hematological Oncology
|
September 7, 2018
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper
Antonio Cuneo, Giovanni Barosi, Romano Danesi, et al.
Oncotarget
|
June 26, 2014
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
Chiara Agnoletto, Elisabetta Melloni, Fabio Casciano, et al.
Blood
|
January 10, 2002
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
Elena Adinolfi, Loredana Melchiorri, Simonetta Falzoni, et al.
European Journal of Haematology
|
October 2, 2004
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings
Gian Matteo Rigolin, Matteo Della Porta, Anna Maria Bugli, et al.
Haematologica
|
December 18, 2023
Towards personalized prevention of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an <I>ad hoc</I> Italian expert panel
Corrado Girmenia, Fabio Ciceri, Paolo Corradini, et al.
Oncotarget
|
September 24, 2016
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 19, 2019
Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the <i>MYD88</i> L265P Gene Mutation
Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, et al.
Page
of 19